Nad+ recalls

The FDA has published 2 recalls involving Nad+ since 2022. The latest was reported on 30 Aug 2023. Most were for sterility. TMC Acquisitions has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.

Total recalls2since 2022

Last 12 months0reported

Class I00% of total

Ongoing1latest 30 Aug 2023

Recalls per month, last 24 months

click a bar for that month

0Dec '24 0 0 0Mar 0 0 0Jun 0 0 0Sep 0 0 0Dec 0 0 0Mar 0 0 0Jun 0 0 0Sep 0 0

Severity split

Class I 0 0%Class II 2 100%Class III 0 0%

Why nad+ is recalled

Sterility2100%

Companies

TMC Acquisitions150%
TMC Acquisition150%

By year

2023150%
2022150%

Ongoing nad+ recalls

1 active

Reported	Class	Recall	Company	Reason	Where
20 Jul 2022Drug	CLASS II	NAD+ 200mg/mL-vial, Refrigerate, Tailor Made Compounding recalled	TMC Acquisition	Sterility	Nationwide

All nad+ recalls, newest first

2 total

Reported	Class	Recall	Company	Reason	Where
30 Aug 2023Drug	CLASS II	NAD+ 200mg/ml vials, Tailor Made Compounding recalled	TMC Acquisitions	Sterility	Nationwide
20 Jul 2022Drug	CLASS II	NAD+ 200mg/mL-vial, Refrigerate, Tailor Made Compounding recalled	TMC Acquisition	Sterility	Nationwide

Should you stop taking Nad+?

Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.